Elena I. Abashova

Elena I. Abashova

Auto-generated profile, based on publicly available information

Elena I. Abashova

D.O. Ott Research Institute of Obstetrics and Gynecology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Gynecological Endocrinology
Verified
Journal Article
Open access
MYMaria Yarmolinskaya
Maria Yarmolinskaya
OBOlga Bulgakova
Olga Bulgakova
EAElena Abashova
Elena Abashova
VBValentina Borodina
Valentina Borodina
TTTatyana Tral
Tatyana Tral
Polycystic ovary syndrome (PCOS) is a widespread endocrine disorder in women of reproductive age. Further research is required to justify new directions of effective targeted therapy of this condit...

15 July 2018 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
MSMaria A. Shalina
Maria A. Shalina
MYMaria Yarmolinskaya
Maria Yarmolinskaya
EAElena I. Abashova
Elena I. Abashova
ШАШалина Мария Александровна
Шалина Мария Александровна
ЯИЯрмолинская Мария Игоревна
Ярмолинская Мария Игоревна
АИАбашова Елена Ивановна
Абашова Елена Ивановна
The paper presents a review of the current literature on the impact of estrogen, progesterone, and estrogen-progestin drugs (combined oral contraceptives, drugs for menopausal hormone therapy), thyroid, and glucocorticoid hormones on bone tissue. In this review, we discuss the pathogenetic mechanisms of the effects of various bioactive compounds on bone, and the results of domestic and foreign research.

8 July 2019 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
EAElena I. Abashova
Elena I. Abashova
MSMaria A. Shalina
Maria A. Shalina
EMElena V. Misharina
Elena V. Misharina
NTNatalia N. Tkachenko
Natalia N. Tkachenko
OBOlga L. Bulgakova
Olga L. Bulgakova
Hypothesis/aims of study. Polycystic ovary syndrome (PCOS) is a common disease, the frequency of which ranges from 8 to 13% in women of reproductive age. PCOS is a complex polygenic endocrine disorder with reproductive, metabolic, and psychological features. Currently, four PCOS phenotypes are identified that are associated with metabolic disorders, insulin resistance, impaired glucose tolerance (IGT), diabetes mellitus, and an increase in the number of risk factors for cardiovascular diseases. The aim of this study was to investigate the clinical features of PCOS phenotypes in women with normogonadotropic anovulation in reproductive age. Study design, materials, and methods. The study included 60 women of reproductive age from 24 to 37 years (mean age 28 ± 4 years) with PCOS and normogogonadotropic, normoprolactinemic anovulation. We studied the levels of anti-mullerian, follicle-stimulating, luteinizing hormone, prolactin, estradiol, and androgens from days 2 to 5 of the menstrual cycle. The serum progesterone level was studied by ELISA using test systems manufactured by Alkor Bio Ltd. (Russia) on days 20–23 of the menstrual cycle for three consecutive cycles. The average level of progesterone in the blood on days 20–23 of the menstrual cycle was 3.1 ± 1.5 nM. Echographic methods for diagnosing polycystic ovaries were used. All women included in the study underwent hysteroscopy on days 18–22 of the menstrual cycle, followed by a histological and immunohistochemical study of the endometrium. Results. In women with anovulatory PCOS phenotypes, phenotype A (classical) was detected in 32 (53.3%) women; phenotype B (anovulatory) in 18 (30%) women; phenotype D (non-androgenic) in 10 (16.7%) women with. In 32 (53.3%) patients, changes in carbohydrate metabolism (IGT) were found. Clinical and biochemical manifestations of androgen-dependent dermopathy (acne, oily seborrhea, and hirsutism) were significantly (p < 0.05) more often observed in PCOS patients with phenotypes A (84.4%) and B (88.9%) than in women with phenotype D (30%). In the majority (93.8%) of patients with IGT, the androgenic-anovulatory PCOS phenotypes were detected: phenotype A in 20 (62.5%) women and phenotype B in 10 (31.3%) women. Phenotype D (non-androgenic) was present only in two women with PCOS and IGT. As a result of complex histological and immunohistochemical studies of endometrial biopsy specimens, chronic endometritis was detected in 44 (73.3%) examined women with PCOS and simple glandular endometrial hyperplasia was diagnosed in 13 (21.7%) PCOS patients. The incidence of chronic endometritis and simple glandular endometrial hyperplasia in women with normogonadotropic anovulation and PCOS directly depended (r = 0.35; p < 0.05) on disorders of carbohydrate metabolism and was detected more often in patients with PCOS and IGT. Conclusion. The differential approach to the examination of patients with various PCOS phenotypes allows personalizing the therapy of this disease and determining the complex of preventive measures to improve the quality of life of women of reproductive age.

29 November 2018 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
EMElena Misharina
Elena Misharina
ATAlena Tiselko
Alena Tiselko
MYMaria Yarmolinskaya
Maria Yarmolinskaya
IKIgor Kogan
Igor Kogan
EAElena Abashova
Elena Abashova
NBNatalia Borovik
Natalia Borovik
Some patients with type 1 diabetes have anovulation, tubal occlusion, male factor and other causes of infertility which require IVF procedure. We examined 20 women with type 1 diabetes, in which pregnancy occurred as a result of ART, at the stage IVF protocol planning, during pregnancy course and delivery. One of the patients underwent IVF procedure twice. Mean age of the patients who applied to the Department of assisted reproductive technologies was 336 years, duration of infertility varied from 3 to 15 years. Two patients were performed donor oocytes transfer (patients with Turner Syndrome and Swyer Syndrome). In 70% of patients the method of CSII was used. Assessment of carbohydrate metabolism was based on the level of glycated hemoglobin A1c (HbA1c), plasma glucose level measured at least 8 times a day and results of continuous glucose monitoring (CGM). 18 singleton pregnancies and three multiple gestations (dichorionic diamniotic twins) occurred as a result of IVF. In 12 women delivery occurred on the 3739th weeks of gestation, in 9 patients pregnancy was terminated on the 3436th weeks. In all the cases it was live birth. Birth weight above the 90th percentile had 6 newborns.

15 September 2016 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
EMElena V Misharina
Elena V Misharina
EAElena I Abashova
Elena I Abashova
VPVladimir V Potin
Vladimir V Potin
The article presents resent date of the pathogenesis and treatment of ovarian insufficiency in obese women and overweight and features and complications of pregnancy and delivery in obese women.

15 April 2021 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
EMElena V. Misharina
Elena V. Misharina
MYMaria Yarmolinskaya
Maria Yarmolinskaya
EAElena I. Abashova
Elena I. Abashova
ЯИЯрмолинская Мария Игоревна
Ярмолинская Мария Игоревна
The incidence of type 1 diabetes mellitus is increasing worldwide, and the number of people with vitamin D deficiency in all age groups, including children and adolescents, is simultaneously growing in the world. Over the past decades, it has been found that vitamin D, in addition to participating in the regulation of calcium homeostasis and bone metabolism, has an anti-inflammatory and immunomodulatory effect. Epidemiological evidence suggests the involvement of vitamin D deficiency in the pathogenesis of type 1 diabetes mellitus. Polymorphisms in genes important for vitamin D metabolism also modulate the risk of type 1 diabetes mellitus. Several studies have evaluated the role of vitamin D as adjuvant immunomodulating therapy in patients with newly diagnosed type 1 diabetes mellitus. The purpose of this review is to present current data on the involvement of vitamin D in the pathogenesis of type 1 diabetes mellitus and to evaluate its role as a drug for the prevention of the disease and its use in treatment in addition to insulin therapy.